Top

LATEST PUBLICATIONS



WHO Experts Say Healthy Kids, Teens May Not Need More COVID Shots

March 29, 2023

Category: Industry, Vaccines

New advice from the World Health Organization (WHO) says healthy children and teens may not need additional COVID-19 shots, though they may need to catch up on other routine vaccines. “The public health impact of vaccinating healthy children and adolescents […]


FDA approves new antifungal as concerns grow over drug-resistant fungus

March 23, 2023

Category: FDA, Regulations

Rezzayo is part of a class of medications known as echinocandins, which are usually the first drugs used to treat patients suffering from bloodstream infections caused by Candida. Unlike the three approved medicines in the class, Rezzayo doesn’t require a […]


New CDC Opioid Guidelines: Too Little, Too Late for Chronic Pain Patients?

March 15, 2023

Category: News

Jessica Layman estimates she has called more than 150 doctors in the past few years in her search for someone to prescribe opioids for her chronic pain. “A lot of them are straight-up insulting,” said the 40-year-old, who lives in […]


News

A small biotech’s shares double on diabetes drug results

March 29, 2023

Via: Biopharma Dive

The results are compelling when compared with approved drugs known as GLP-1 agonists that showed a reduction of between 0.5% and 0.8% in A1C after four weeks of treatment, Jefferies analysts wrote in a note to clients. Biomea also has […]


News

Intra-Cellular shares rise on depression study’s success

March 28, 2023

Via: Biopharma Dive

Shares of Intra-Cellular Therapies rocketed up Tuesday morning, after the New York-based biotechnology company unveiled positive clinical trial results for a depression medication that some analysts called a “clear win.” The medication, known scientifically as lumateperone and commercially as Caplyta, […]


Clinical Trials, Research and Development

Viking joins obesity drug development race with early study data

March 28, 2023

Via: Biopharma Dive

Novo Nordisk pioneered the use of insulin-stimulating diabetes drugs as weight loss treatments when it launched a high-dose version of its daily shot Victoza as Saxenda in 2014. It followed on that success years later with a weekly shot, marketed […]


FDA, Regulations

BrainStorm files ALS drug application over FDA protest

March 27, 2023

Via: Biopharma Dive

A yearslong disagreement between the Food and Drug Administration and a developer of an experimental medicine for ALS will get a public hearing sometime in the future, setting up another high-profile debate of what amount of evidence merits an approval […]


Clinical Trials, Industry, Research and Development, Vaccines

BioNTech Revenues Slide with Waning Demand for COVID-19 Vaccines

March 27, 2023

Via: Contract Pharma

4Q Revenues: €4.3 billion (-23%) 4Q Earnings: €2.3 billion (-28%) YTD Revenues: €17.3 billion (-9%) YTD Earnings: €9.3 billion (-8%) Comments: Results in the quarter and FY reflect lower demand for COVID-19 vaccines. Approximately 2 billion doses of COMIRNATY invoiced […]


Mergers and Acquisitions

Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development

March 24, 2023

Via: Biopharm International

Curia announced on March 23, 2023 that it is collaborating with Corning to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical industries globally. The collaboration marks the first global installation of Corning’s G1 production system […]


Mergers and Acquisitions

Harm Reduction Therapeutics, Catalent Ink Naloxone Commercial Supply Pact

March 24, 2023

Via: Contract Pharma

Harm Reduction Therapeutics, a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths, signed a commercial supply agreement with Catalent for the manufacture Harm Reduction Therapeutics’ naloxone nasal spray, RiVive (3.0 mg), for the emergency treatment of […]